Allergan vows limited price hikes, says ‘outliers’ deter research

(Reuters) – The chief executive officer of Allergan Plc said his company would limit annual price increases on its prescription drugs, and that “outlier” drugmakers that have imposed huge price increases on their products were scaring off venture capital investors.

(Reuters) – The chief executive officer of Allergan Plc said his company would limit annual price increases on its prescription drugs, and that "outlier" drugmakers that have imposed huge price increases on their products were scaring off venture capital investors.
Original Article

more recommended stories